Funds Cut for HIV/Aids Programs

Published December 20, 2010

Funds Cut for HIV/Aids Programs
State and Federal cuts to funds allocated to HIV and Aids programs are being felt locally in Shreveport. With less money for prevention, testing, and treatment, the number of infected people could rise.
Read more on KTBS Shreveport

FDA says Avastin no longer should be breast cancer drug
The controversial and expensive cancer drug Avastin may be losing its FDA approval for treating breast cancer.
Read more on Milwaukee Journal Sentinel

FFR-guided percutaneous coronary intervention provides cost-saving benefits
St. Jude Medical, Inc., a global medical device company, today announced the publication of results from an economic evaluation of the landmark FAME (Fractional Flow Reserve (FFR) vs. Angiography in Multivessel Evaluation) trial, which confirmed FFR-guided percutaneous coronary intervention (PCI) in patients with multivessel coronary artery disease improves patient outcomes and offers cost …
Read more on News-Medical-Net